1. Home
  2. DXCM vs EXPE Comparison

DXCM vs EXPE Comparison

Compare DXCM & EXPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DXCM
  • EXPE
  • Stock Information
  • Founded
  • DXCM 1999
  • EXPE 1996
  • Country
  • DXCM United States
  • EXPE United States
  • Employees
  • DXCM N/A
  • EXPE N/A
  • Industry
  • DXCM Medical/Dental Instruments
  • EXPE Transportation Services
  • Sector
  • DXCM Health Care
  • EXPE Consumer Discretionary
  • Exchange
  • DXCM Nasdaq
  • EXPE Nasdaq
  • Market Cap
  • DXCM 28.0B
  • EXPE 22.4B
  • IPO Year
  • DXCM 2005
  • EXPE 1999
  • Fundamental
  • Price
  • DXCM $79.35
  • EXPE $191.41
  • Analyst Decision
  • DXCM Buy
  • EXPE Buy
  • Analyst Count
  • DXCM 17
  • EXPE 29
  • Target Price
  • DXCM $101.29
  • EXPE $166.00
  • AVG Volume (30 Days)
  • DXCM 4.0M
  • EXPE 1.6M
  • Earning Date
  • DXCM 10-24-2024
  • EXPE 11-07-2024
  • Dividend Yield
  • DXCM N/A
  • EXPE N/A
  • EPS Growth
  • DXCM 83.21
  • EXPE 39.78
  • EPS
  • DXCM 1.67
  • EXPE 7.63
  • Revenue
  • DXCM $3,954,000,000.00
  • EXPE $13,394,000,000.00
  • Revenue This Year
  • DXCM $13.10
  • EXPE $7.88
  • Revenue Next Year
  • DXCM $14.79
  • EXPE $7.90
  • P/E Ratio
  • DXCM $48.58
  • EXPE $24.68
  • Revenue Growth
  • DXCM 16.19
  • EXPE 6.56
  • 52 Week Low
  • DXCM $62.34
  • EXPE $107.25
  • 52 Week High
  • DXCM $142.00
  • EXPE $190.40
  • Technical
  • Relative Strength Index (RSI)
  • DXCM 67.60
  • EXPE 71.99
  • Support Level
  • DXCM $77.50
  • EXPE $182.57
  • Resistance Level
  • DXCM $82.26
  • EXPE $187.40
  • Average True Range (ATR)
  • DXCM 2.33
  • EXPE 3.55
  • MACD
  • DXCM 0.52
  • EXPE -0.37
  • Stochastic Oscillator
  • DXCM 81.49
  • EXPE 99.38

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

About EXPE Expedia Group Inc.

Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of total 2023 sales), air tickets (3%), rental cars, cruises, in-destination, and other (11%), and advertising revenue (6%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.

Share on Social Networks: